0 Table of Contents |
1 Home |
2 2022 CDC Clinical Practice Guideline - Profiles |
3 2022 CDC Clinical Practice Guideline - Terminology |
4 2022 CDC Clinical Practice Guideline - Examples |
5 2022 CDC Clinical Practice Guideline - Documentation |
5.1 2022 CDC Clinical Practice Guideline - Implementation Documentation |
5.2 2022 CDC Clinical Practice Guideline - Integration Documentation |
5.3 2022 CDC Clinical Practice Guideline - Process Documentation |
5.4 2022 CDC Clinical Practice Guideline - Service Documentation |
6 2022 CDC Clinical Practice Guideline - Downloads |
7 2022 CDC Clinical Practice Guideline - Acute Pain |
8 2022 CDC Clinical Practice Guideline - Quick Start |
9 Chronic Pain Decision Documentation |
10 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration |
10.1 OpioidCDS Recommendation 01 - CQL Source |
11 Recommendation #2 - Opioid Therapy Goals Discussion |
11.1 OpioidCDS Recommendation 02 - CQL Source |
12 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy |
12.1 OpioidCDS Recommendation 03 - CQL Source |
13 Recommendations #4 and #5 - Lowest Effective Dose |
13.1 OpioidCDS Recommendations 04 and 05 - CQL Source |
14 Recommendation #6 - Prescribe Lowest Effective Dose and Duration |
14.1 OpioidCDS Recommendation 06 - CQL Source |
15 Recommendation #7 - Opioid Therapy Risk Assessment |
15.1 OpioidCDS Recommendation 07 - CQL Source |
16 Recommendation #8 - Naloxone Consideration |
16.1 OpioidCDS Recommendation 08 - CQL Source |
17 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions |
17.1 OpioidCDS Recommendation 09 - CQL Source |
18 Recommendation #10 Order Sign Variation - Urine Drug Testing |
18.1 OpioidCDS Recommendation 10 Order Sign - CQL Source |
19 Recommendation #10 Patient View Variation - Urine Drug Testing |
19.1 OpioidCDS Recommendation 10 Patient View - CQL Source |
20 Recommendation #11 Order Select Variation - Concurrent Use of Opioids and Benzodiazepines |
20.1 OpioidCDS Recommendation 11 Order Select - CQL Source |
21 Recommendation #11 Patient View Variation - Concurrent Use of Opioids and Benzodiazepines |
21.1 OpioidCDS Recommendation 11 Patient View - CQL Source |
22 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder |
22.1 OpioidCDS Recommendation 12 (patient-view) - CQL Source |
23 License and Legal Terms |
24 Artifacts Summary |
24.1 HelloWorld |
24.2 HelloWorldPatientView |
24.3 CDCMMEClinicalConversionFactors |
24.4 OpioidCDSRoutines |
24.5 OpioidCDSCommon |
24.6 OpioidCDSCommonConfig |
24.7 OpioidLogicMK2020 |
24.8 OpioidData2020 |
24.9 FHIRHelpers |
24.10 FHIRModelInfo |
24.11 OpioidCDSREC10CommonLibrary |
24.12 OpioidCDSREC01Library |
24.13 OpioidCDSREC02Library |
24.14 OpioidCDSREC03Library |
24.15 OpioidCDSREC04And05Library |
24.16 OpioidCDSREC06Library |
24.17 OpioidCDSREC07Library |
24.18 OpioidCDSREC08Library |
24.19 OpioidCDSREC09Library |
24.20 OpioidCDSREC10Library |
24.21 OpioidCDSREC10PatientViewLibrary |
24.22 OpioidCDSREC11Library |
24.23 OpioidCDSREC11PatientViewLibrary |
24.24 OpioidCDSREC12PatientViewLibrary |
24.25 OpioidRiskAssessmentActivityDefinition |
24.26 OpioidUrineScreeningActivityDefinition |
24.27 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #1 |
24.27.1 Library |
24.28 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #2 |
24.28.1 Library |
24.29 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #3 |
24.29.1 Library |
24.30 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendations #4 and #5 |
24.30.1 Library |
24.31 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #6 |
24.31.1 Library |
24.32 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #7 |
24.32.1 Library |
24.33 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 (order-sign) |
24.33.1 Library |
24.34 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 |
24.34.1 Library |
24.35 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #9 |
24.35.1 Library |
24.36 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (order-sign) |
24.36.1 Library |
24.37 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (patient-view) |
24.37.1 Library |
24.38 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 |
24.38.1 Library |
24.39 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 (patient-view) |
24.39.1 Library |
24.40 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 |
24.40.1 Library |
24.41 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #12 (patient-view) |
24.41.1 Library |
24.42 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4 |
24.43 Morphine Milligram Equivalent (MME) Calculator for FHIR R4 |
24.44 Opioid Management Terminology Knowledge Data |
24.45 Opioid Management Terminology Knowledge Logic |
24.46 CDC_CarePlan |
24.47 CDC_MedicationRequest |
24.48 CDC_Observation |
24.49 CDC_RequestGroup |
24.50 CDC_ValueSet |
24.51 DataDateRollerExtension |
24.52 EffectiveDataRequirement Extension |
24.53 CDC 2022 Opioid Guidance Clinical Focus Extension |
24.54 CDC 2022 Opioid Guidance Data Element Extension |
24.55 CDC 2022 Opioid Guidance exclusion Criteria Extension |
24.56 CDC 2022 Opioid Guidance Inclusion Criteria Extension |
24.57 CodeSystem - CDC 2022 Opioid Indicator |
24.58 OpioidCDS CarePlan |
24.59 Cancer Diagnosis Condition |
24.60 End of Life Condition |
24.61 Terminal Condition |
24.62 Cancer Diagnosis Encounter |
24.63 Oncology Participant Encounter |
24.64 Ambulatory Opioid MedicationDispense |
24.65 OpioidCDS MedicationRequest |
24.66 Ambulatory Opioid MedicationRequest |
24.67 OpioidCDS Observation |
24.68 OpioidCDS Patient |
24.69 Oncology Specialist PractitionerRole |
24.70 OpioidCDS RequestGroup |
24.71 Palliative Care ServiceRequest |
24.72 Ethanol urine drug screening tests |
24.73 Amphetamine-class drugs and metabolite urine tests |
24.74 Amphetamine class medications |
24.75 Benzodiazepine medications |
24.76 Buprenorphine and Methadone medications |
24.77 Cannabinoid class urine drug screening |
24.78 CDC malignant cancer conditions |
24.79 CNS depressant medications |
24.80 Cocaine urine drug screening tests |
24.81 Sleep disordered breathing |
24.82 Conditions documenting substance misuse |
24.83 Conditions likely terminal for opioid prescribing |
24.84 Extended release opioid with ambulatory misuse potential |
24.85 Fentanyl-type medications |
24.86 Fentanyl-type urine drug screening tests |
24.87 General opiate urine drug screening tests |
24.88 Hospice Finding |
24.89 Hospice Procedure |
24.90 Limited life expectancy conditions |
24.91 Methadone urine drug screening tests |
24.92 Methadone medications |
24.93 Naloxone medications |
24.94 Ambulatory setting non-opioid CNS depressant medications |
24.95 Non-opioid drug urine screening |
24.96 Non-synthetic opioid medications |
24.97 Oncology specialty designations (NUCC) |
24.98 Opiate specific urine drug screening tests |
24.99 Opioid analgesics with ambulatory misuse potential |
24.100 Opioid counseling procedure |
24.101 Opioid drug urine screening |
24.102 Opioid misuse assessment procedure |
24.103 Opioid misuse disorders |
24.104 Opioid treatment assessment procedure |
24.105 Pain management procedure |
24.106 Pain treatment plan |
24.107 PDMP data reviewed finding |
24.108 PDMP review procedure |
24.109 Phencyclidine urine drug screening tests |
24.110 Sickle-cell diseases |
24.111 Substance misuse behavioral counseling |
24.112 Synthetic opioid medications |
24.113 Synthetic opioid urine drug screening tests |
24.114 Therapies indicating end of life care |
24.115 Condition Clinical Status Active |
24.116 Encounter Diagnosis Condition Category |
24.117 Problem List Condition Category |
24.118 US Core Health Concern Condition Category |
24.119 Hospice Disposition |
24.120 Observation Category Laboratory |
24.121 Observation Category Procedure |
24.122 Office Visit |
24.123 CQFToolingDevice |